Literature DB >> 21167889

NS5A inhibitors: a new breakthrough for the treatment of chronic hepatitis C.

Tarik Asselah1.   

Abstract

Entities:  

Year:  2010        PMID： 21167889     DOI： 10.1016/j.jhep.2010.11.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

1.  Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core.

Authors:  Il Hak Bae; Jin Kyu Choi; Chieyeon Chough; Sun Ju Keum; Heesun Kim; Sung Key Jang; B Moon Kim
Journal:  ACS Med Chem Lett       Date:  2013-12-04       Impact factor: 4.345

Review 2.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutations.

Authors:  Garvita Gupta; Haina Qin; Jianxing Song
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

Review 4.  Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis.

Authors:  Seyed Moayed Alavian; Mohammad Saeid Rezaee-Zavareh
Journal:  Hepat Mon       Date:  2016-08-22       Impact factor: 0.660

5.  Androgen Receptor Is Inactivated and Degraded in Bladder Cancer Cells by Phenyl Glucosamine via miR-449a Restoration.

Authors:  Ju Guo; Jieping Hu; Runfu Cao; Qingsheng Chen; Kanghua Li
Journal:  Med Sci Monit       Date:  2018-04-16

Review 6.  HCV direct-acting antiviral agents: the best interferon-free combinations.

Authors:  Raymond Schinazi; Philippe Halfon; Patrick Marcellin; Tarik Asselah
Journal:  Liver Int       Date:  2014-02       Impact factor: 5.828

7.  Synthesis and evaluation of non-dimeric HCV NS5A inhibitors.

Authors:  Franck Amblard; Hongwang Zhang; Longhu Zhou; Junxing Shi; Drew R Bobeck; James H Nettles; Satish Chavre; Tamara R McBrayer; Philip Tharnish; Tony Whitaker; Steven J Coats; Raymond F Schinazi
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

Review 8.  The role of HCV proteins on treatment outcomes.

Authors:  Kattareeya Kumthip; Niwat Maneekarn
Journal:  Virol J       Date:  2015-12-15       Impact factor: 4.099
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.